IMPDH2 and cancer: Interestingly, MPA treatment also resulted in a significant reduction in plasma-membrane-associated IMPDH2 in A549 and H358 cells (Figure 2F,G), suggesting that this may represent the key active pool of IMPDH2 in cancer cells.